The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence
DOI:
https://doi.org/10.14739/2310-1210.2023.3.251479Keywords:
obesity, metabolic syndrome, polycystic ovary syndrome, adolescence, diagnosis, treatment, preventionAbstract
The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary-dependent pathology. One of the major consequences of weight problems is metabolic syndrome (MS).
There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension).
Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome typical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia).
First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.
References
Antypkin, Yu. H., Horban, N. Ye., & Lutsenko, O. H. (2021). Faktory ryzyku rozvytku khvorob tsyvilizatsii [Risk factors for the development of civilization diseases]. Zdorovia Ukrainy. (Akusherstvo Hinekolohia Reproduktolohiia), (1), 8-12. [in Ukrainian].
Zhuk, S. I., & Gordiychuk, A B. (2018). SPKYa: fenotipy, vistseralnoe ozhirenie i personalizirovannyi podkhod v naznachenii KOK [PCOS: phenotypes, visceral obesity and a personalized approach in the prescription of COC]. Reproductive Endocrinology, (2), 34-41. [in Russian]. https://doi.org/10.18370/2309-4117.2018.40.34-41
GBD 2015 Obesity Collaborators, Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., Estep, K., Lee, A., Marczak, L., Mokdad, A. H., Moradi-Lakeh, M., Naghavi, M., Salama, J. S., Vos, T., Abate, K. H., Abbafati, C., Ahmed, M. B., Al-Aly, Z., Alkerwi, A., Al-Raddadi, R., Amare, A. T., … Murray, C. J. L. (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. The New England journal of medicine, 377(1), 13-27. https://doi.org/10.1056/NEJMoa1614362
Syusyuka, V. G., Sergienko, M. Y., Makurina, G. I., Yershova, O. A., & Chornenka, A. S. (2021). Syndrom polikistoznykh yaiechnykiv: kliniko-patohenetychni aspekty multydystsyplinarnoi problemy [Polycystic ovary syndrome:clinical and pathogenetic aspects of a multidisciplinary problem]. Reproductive Health of Woman, (2), 7-14. [in Ukrainian]. https://doi.org/10.30841/2708-8731.2.2021.232513
Song, M., & Giovannucci, E. (2018). Substitution analysis in nutritional epidemiology: proceed with caution. European journal of epidemiology, 33(2), 137-140. https://doi.org/10.1007/s10654-018-0371-2
Semeniuk, L. M., Yuzvenko, T. Yu., & Larina, O. V. (2018). Osoblyvosti vuhlevodnoho obminu u zhinok rannoho reproduktyvnoho viku iz skleropolikistozom yaiechnykiv [Features of carbohydrate metabolism in women of early reproductive age with polycystic ovary syndrome]. Mizhnarodnyi endokrynolohichnyi zhurnal, 14(3), 236-241. [in Ukrainian]. https://doi.org/10.22141/2224-0721.14.3.2018.136417
DeBoer, M. D., Filipp, S. L., & Gurka, M. J. (2019). Geographical variation in the prevalence of obesity and metabolic syndrome among US adolescents. Pediatric obesity, 14(4), e12483. https://doi.org/10.1111/ijpo.12483
Shmyhol, I. V., & Dubenets, D. S. (2021). Poshyrenist nadmirnoi vahy ta ozhyrinnia sered shkoliariv silskoi mistsevosti [Prevalence of overweight and obesity among rural schoolchildren]. Zbirnyk naukovykh prats ΛΌHOΣ (Vol. 1), (pp. 137-139). [in Ukrainian]. https://doi.org/10.36074/logos-28.05.2021.v1.42
DeBoer, M. D. (2019). Assessing and Managing the Metabolic Syndrome in Children and Adolescents. Nutrients, 11(8), 1788. https://doi.org/10.3390/nu11081788
O'Connor, E. A., Evans, C. V., Burda, B. U., Walsh, E. S., Eder, M., & Lozano, P. (2017). Screening for Obesity and Intervention for Weight Management in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 317(23), 2427-2444. https://doi.org/10.1001/jama.2017.0332
Sergiyenko, M. Yu., Siusiuka, V. G., Makurina, G. I., Deinichenko, O. V. Kolokot, N. G., & Chornenka, A. S. (2022). Modern approaches to the diagnosis and treatment of polycystic ovary syndrome in adolescence. Reproductive Health of Woman, (2), 73-78. https://doi.org/10.30841/2708-8731.2.2022.261816
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020). Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC medicine, 18(1), 72. https://doi.org/10.1186/s12916-020-01516-x
Teede, H., Misso, M., Costello, M., Dokras, A., Laven, J., Moran, L., Piltonen T., & Norman, R. (2018). International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. National Health and Medical Research Council (NHMRC) (pp. 1-198). https://www.monash.edu/medicine/sphpm/mchri/pcos/guideline
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., Garcia Rudaz, C., Hoeger, K. M., López-Bermejo, A., Ong, K., Peña, A. S., Reinehr, T., Santoro, N., Tena-Sempere, M., Tao, R., Yildiz, B. O., … Lee, P. A. (2017). An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Hormone research in paediatrics, 88(6), 371-395. https://doi.org/10.1159/000479371
Fornari, E., & Maffeis, C. (2019). Treatment of Metabolic Syndrome in Children. Frontiers in endocrinology, 10, 702. https://doi.org/10.3389/fendo.2019.00702
Gurka, M. J., Golden, S. H., Musani, S. K., Sims, M., Vishnu, A., Guo, Y., Cardel, M., Pearson, T. A., & DeBoer, M. D. (2017). Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia, 60(7), 1261-1270. https://doi.org/10.1007/s00125-017-4267-6
DeBoer, M. D., Filipp, S. L., Sims, M., Musani, S. K., & Gurka, M. J. (2020). Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity. Stroke, 51(8), 2548-2552. https://doi.org/10.1161/STROKEAHA.120.028944
DeBoer, M. D., Filipp, S. L., Musani, S. K., Sims, M., Okusa, M. D., & Gurka, M. (2018). Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study. Kidney & blood pressure research, 43(2), 555-567. https://doi.org/10.1159/000488829
Leong, K. S. W., Jayasinghe, T. N., Wilson, B. C., Derraik, J. G. B., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., Jiang, Y., Schierding, W., Vatanen, T., Holland, D. J., O'Sullivan, J. M., & Cutfield, W. S. (2020). High prevalence of undiagnosed comorbidities among adolescents with obesity. Scientific reports, 10(1), 20101. https://doi.org/10.1038/s41598-020-76921-6
Kaminskyi, V. V., Tatarchuk, T. F., & Dubossarska, Y. O. (2016). Natsionalnyi konsensus shchodo vedennia patsiientok iz hiperandroheniieiu [National consensus on the management of patients with hyperandrogenism (2016)]. Reproductive Endocrinology, (4), 19-31. [in Ukrainian]. https://doi.org/10.18370/2309-4117.2016.30.19-31
Avramenko N. V., Kabachenko O. V., Barkovskyi D. Ye., & Sierykh K. V. (2020). Suchasni aspekty menedzhmentu patsiientok iz syndromom polikistozu yaiechnykiv [Modern aspects of management of patients with polycystic ovary syndrome]. Zaporozhye medical journal, 22(6). 865-873. [in Ukrainian]. https://doi.org/10.14739/2310-1210.2020.6.218474
Cheng, T. S., Day, F. R., Lakshman, R., & Ong, K. K. (2020). Association of puberty timing with type 2 diabetes: A systematic review and meta-analysis. PLoS medicine, 17(1), e1003017. https://doi.org/10.1371/journal.pmed.1003017
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018). Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Human reproduction update, 24(4), 455-467. https://doi.org/10.1093/humupd/dmy007
Caroppo, F., Galderisi, A., Ventura, L., & Belloni Fortina, A. (2021). Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis. European journal of pediatrics, 180(6), 1739-1745. https://doi.org/10.1007/s00431-020-03924-w
Tagi, V. M., Giannini, C., & Chiarelli, F. (2019). Insulin Resistance in Children. Frontiers in endocrinology, 10, 342. https://doi.org/10.3389/fendo.2019.00342
Cassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016). Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Human reproduction, 31(11), 2619-2631. https://doi.org/10.1093/humrep/dew243
Tatarchuk, T. F. (2021). Yak podolaty insulinorezystentnist pry syndromi polikistoznykh yayechnykiv? [How to overcome insulin resistance in polycystic ovary syndrome?]. Zdorovia Ukrainy. (Akusherstvo Hinekolohia Reproduktolohiia), (1), 3-4. [in Ukrainian].
Spartano, N. L., Stevenson, M. D., Xanthakis, V., Larson, M. G., Andersson, C., Murabito, J. M., & Vasan, R. S. (2017). Associations of objective physical activity with insulin sensitivity and circulating adipokine profile: the Framingham Heart Study. Clinical obesity, 7(2), 59-69. https://doi.org/10.1111/cob.12177
Kim, Y., & Je, Y. (2019). Early Menarche and Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Journal of women's health (2002), 28(1), 77-86. https://doi.org/10.1089/jwh.2018.6998
Moslehi, N., Asghari, G., Mirmiran, P., & Azizi, F. (2021). Longitudinal association of dietary sources of animal and plant protein throughout childhood with menarche. BMC pediatrics, 21(1), 206. https://doi.org/10.1186/s12887-021-02670-8
Šaffa, G., Kubicka, A. M., Hromada, M., & Kramer, K. L. (2019). Is the timing of menarche correlated with mortality and fertility rates?. PloS one, 14(4), e0215462. https://doi.org/10.1371/journal.pone.0215462
Farahmand, M., Tehrani, F. R., Dovom, M. R., & Azizi, F. (2017). Menarcheal Age and Risk of Type 2 Diabetes: A Community-Based Cohort Study. Journal of clinical research in pediatric endocrinology, 9(2), 156-162. https://doi.org/10.4274/jcrpe.3370
Peña, A. S., Doherty, D. A., Atkinson, H. C., Hickey, M., Norman, R. J., & Hart, R. (2018). The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study. Archives of disease in childhood, 103(3), 235-239. https://doi.org/10.1136/archdischild-2017-312968
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017). Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome. The Journal of adolescent health, 60(3), 333-339. https://doi.org/10.1016/j.jadohealth.2016.10.015
Morley, L. C., Tang, T., Yasmin, E., Norman, R. J., & Balen, A. H. (2017). Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. The Cochrane database of systematic reviews, 11(11), CD003053. https://doi.org/10.1002/14651858.CD003053.pub6
Uysal, G., Sahin, Y., Unluhizarci, K., Ferahbas, A., Uludag, S. Z., Aygen, E., & Kelestimur, F. (2017). Is acne a sign of androgen excess disorder or not? European Journal of Obstetrics & Gynecology, and Reproductive Biology, 211, 21-25. https://doi.org/10.1016/j.ejogrb.2017.01.054
Scheitel, M. R., Kessler, M. E., Shellum, J. L., Peters, S. G., Milliner, D. S., Liu, H., Komandur Elayavilli, R., Poterack, K. A., Miksch, T. A., Boysen, J., Hankey, R. A., & Chaudhry, R. (2017). Effect of a Novel Clinical Decision Support Tool on the Efficiency and Accuracy of Treatment Recommendations for Cholesterol Management. Applied clinical informatics, 8(1), 124-136. https://doi.org/10.4338/ACI-2016-07-RA-0114
Tatarchuk, T. F., & Kaluhina, L. V. (2018). Perspektyvy vykorystannia inozytoliv u korektsii insulinorezystentnosti u zhinok iz syndromom polikistoznykh yaiechnykiv [Prospects for the use of inositols in the correction of insulin resistance in women with polycystic ovary syndrome]. Zdorovia Ukrainy. (Hinekolohiia, Akusherstvo, Reproduktolohiia), (1), 5-6. [in Ukrainian].
Soliman, A., De Sanctis, V., Alaaraj, N., & Hamed, N. (2020). The clinical application of metformin in children and adolescents: A short update. Acta bio-medica : Atenei Parmensis, 91(3), e2020086. https://doi.org/10.23750/abm.v91i3.10127
Faculty of Sexual & Reproductive Healthcare. (2020). FSRH Clinical Guideline: Combined Hormonal Contraception (January 2019, Amended November 2020). https://www.fsrh.org/standards-and-guidance/documents/combined-hormonal-contraception/
Kalugina, L. V., & Yusko, T. I. (2018). Mio-inozitol: terapevticheskie vozmozhnosti i pregravidarnaya podgotovka pri sindrome polikistoznykh yaichnikov. Obzor literatury [Myo-inositol: therapeutic possibilities and pregravid preparation in women with pcos]. Reproductive Endocrinology, (4), 40-45. [in Russian]. https://doi.org/10.18370/2309-4117.2018.42.40-45
Lang, A. Y., Boyle, J. A., Fitzgerald, G. L., Teede, H., Mazza, D., Moran, L. J., & Harrison, C. (2018). Optimizing preconception health in women of reproductive age. Minerva ginecologica, 70(1), 99-119. https://doi.org/10.23736/S0026-4784.17.04140-5
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
